Loading...
Dernières publications
-
Hélène Bricout, Marie‐cécile Levant, Nada Assi, Pascal Crepey, Alexandre Descamps, et al.. The relative effectiveness of a high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccines in older adults in France: a retrospective cohort study during the 2021-22 influenza season. Clinical Microbiology and Infection, 2024, ⟨10.1016/j.cmi.2024.08.012⟩. ⟨hal-04698967⟩
-
Mathieu Chalouni, Paul Loubet, Edouard Lhomme, Laetitia Ninove, Benoit Barrou, et al.. Association between humoral serological markers levels and risk of SARS-CoV-2 infection after the primary COVID-19 vaccine course among ANRS0001S COV-POPART cohort participants. BMC Infectious Diseases, 2024, 24 (1), pp.1049. ⟨10.1186/s12879-024-09861-5⟩. ⟨hal-04724620⟩
-
Christine Durier, Laetitia Ninove, Sylvie van der Werf, Maeva Lefebvre, Corinne Desaint, et al.. Incidence of COVID-19 mRNA vaccine symptomatic breakthrough infections during Omicron circulation in adults with or without infection prior to vaccination. Infectious Diseases Now, 2024, 54 (5), pp.104886. ⟨10.1016/j.idnow.2024.104886⟩. ⟨hal-04596145⟩
Le CIC-1417 sur Twitter
Documents en texte intégral
88
Notices
64
Mots clés
ANTIRETROVIRAL THERAPY
Attitudes of health personnel
Conjugate pneumococcal vaccine
COVID-19 vaccines
Vaccine effectiveness
AIDS
B-lymphocytes
Alpha variant
Incidence
Older adults
Respiratory syncytial virus
Influenza-like illness
Dendritic cells
HPV vaccine
Sleep
Confidence
Deletion
Cohort
Immunization
Antiviral
Antiretroviral therapy
Booster response
Antiviral agents
Internet
Clinical practice
Hospitalisations
Co-morbidities
COCONEL cohort surveys
Covidom
C-type lectin receptor
Attitudes
Immunogenicity
Vaccines
COVID-19 mRNA vaccine
Coadministration
AstraZeneca vaccine
1790GAHB F
Vaccine hesitancy
Bayes' theorem
Adjuvant
Cystic fibrosis
SARS-CoV-2
Attitude to health
Vaccination
HIV
Acute kidney injury
Digital care
Dialysis
AON
Practices
Care management
Coronavirus
Boys
Clinical research
Specific populations
Covid 19
COVID-19
DMD
Covid-19
Vaccine safety and efficacy
Diabetes mellitus type 2
Determinant
Misinformation
Catch-up
Awareness
Vaccine acceptance
Assay
Cohort study
Biomarkers
Efficacy
Healthcare workers
Conditional marketing authorization
Chemotherapy
Immunocompromised
Cancer
Virology
Data sharing
CERVICOVAGINAL SECRETIONS
Clinical skills
Innate immunity
France
Breakthrough infections
Chronic kidney disease
Influenza
Epidemiology
Attitude
Adverse effects
Cost of illness
Calcium phosphorus evaluation
Delphi study
Risk factors
Hesitancy
Determinants
Elderly
Antiviral therapy
Vaccine
Clinical trials
Adults
Adenoviral vector
Effectiveness